In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery

International Journal of Pharmaceutics

Volumn 356, Issue 1-2, 2008, Pages 95-101

  Itoh, Kunihiko ^a   Yahaba, Masayuki ^a   Takahashi, Akie ^a   Tsuruya, Reina ^a   Miyazaki, Shozo ^a   Dairaku, Masatake ^b   Togashi, Mitsuo ^b   Mikami, Ryozo ^b   Attwood, David ^c  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b Teikoku Medix Co Ltd   (Japan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

In situ gelation; Oral drug delivery; Paracetamol; Pectin; Sustained release; Xyloglucan

Indexed keywords

GLUCAN; PARACETAMOL; PECTIN; XYLOGLUCAN;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DIFFUSION; EXCIPIENTS; GELS; GLUCANS; MALE; PECTINS; PHARMACEUTICAL SOLUTIONS; RATS; RATS, WISTAR; RHEOLOGY; XYLANS;

EID: 42649097899     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.12.049     Document Type: Article

References (32)

1. Ameer B., Greenblatt D.J., Divoll M., Abernethy D.R., and Shargel L. High-performance liquid chromatographic determination of acetaminophen in plasma: single-dose pharmacokinetic studies. J. Chromatogr. 226 (1981) 224-230
2. 2+-induced gelation in alginates and pectins: the egg-box model revisited. Biomacromolecules 2 (2001) 1089-1096
3. Burgalassi S., Chetoni P., Panichi L., Boldrini E., and Saettone M.F. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits. J. Ocul. Pharmacol. Ther. 16 (2000) 497-509
4. Dea I.C.M., McKinnon A.A., and Rees D.A. Tertiary and quaternary structure in aqueous polysaccharide systems which model cell wall cohesion: reversible changes in conformation and association of agarose, carrageenan and galactomannans. J. Mol. Biol. 68 (1972) 153-172
5. Fairbrother J.E. Acetaminophen. In: Florey K. (Ed). Analytical Profiles of Drug Substances vol. 3 (1974), Academic Press, New York 1-109
6. Gilsenan P.M., Richardson R.K., and Morris E.R. Thermally reversible acid-induced gelation of low-methoxy pectin. Carbohydr. Polym. 41 (2000) 339-349
7. Higuchi W.I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51 (1962) 802-804
8. Itoh K., Kubo W., Fujiwara M., Watanabe H., Miyazaki S., and Attwood D. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol. Pharm. Bull. 29 (2006) 343-347
9. Itoh K., Kubo W., Fujiwara M., Hirayama T., Miyazaki S., Dairaku M., Togashi M., Mikami R., and Attwood D. The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations. Int. J. Pharm. 312 (2006) 37-42
10. Itoh K., Hirayama T., Takahashi A., Kubo W., Miyazaki S., Dairaku M., Togashi M., Mikami R., and Attwood D. In situ pectin formulations for oral drug delivery at high gastric pH. Int. J. Pharm. 335 (2007) 90-96
11. Kawasaki N., Ohkura R., Miyazaki S., Uno Y., Sugimoto S., and Attwood D. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int. J. Pharm. 181 (1999) 227-234
12. Kubo W., Miyazaki S., Dairaku M., Togashi M., Mikami R., and Attwood D. Oral sustained delivery of ambroxol from in situ-gelling pectin formulations. Int. J. Pharm. 271 (2004) 233-240
13. Kubo W., Konno Y., Miyazaki S., and Attwood D. In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev. Ind. Pharm. 30 (2004) 593-599
14. Kubo W., Itoh K., Miyazaki S., and Attwood D. Oral sustained delivery of theophylline and cimetidine from in situ gelling pectin formulations in rabbits. Drug Dev. Ind. Pharm. 31 (2005) 819-825
15. Lin H.-R., Sung K.C., and Vong W.-J. In situ gelling of alginate/Pluronic solutions for ophthalmic delivery of pilocarpine. Biomacromolecules 5 (2004) 2358-2365
16. Miyazaki S., Takeuchi S., Yokouchi C., and Takada M. Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. Chem. Pharm. Bull. 32 (1984) 4205-4208
17. Miyazaki S., Suisha F., Kawasaki N., Shirakawa M., Yamatoya K., and Attwood D. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J. Control. Rel. 56 (1998) 75-83
18. Miyazaki S., Suzuki S., Kawasaki N., Endo K., Takahashi A., and Attwood D. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int. J. Pharm. 229 (2001) 29-36
19. Miyazaki S., Kawasaki N., Endo K., and Attwood D. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits. J. Pharm. Pharmacol. 53 (2001) 1185-1191
20. Miyazaki S., Endo K., Kawasaki N., Kubo W., Watanabe H., and Attwood D. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev. Ind. Pharm. 29 (2003) 113-119
21. Miyazaki S., Kubo W., Itoh K., Konno Y., Fujiwara M., Dairaku M., Togashi M., Mikami R., and Attwood D. The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol. Int. J. Pharm. 297 (2005) 38-49
22. Morris E.R., Powell D.A., Gidley M.J., and Rees D.A. Conformations and interactions of pectins: I. Polymorphism between gel and solid states of calcium polygalacturonate. J. Mol. Biol. 155 (1982) 507-516
23. Morris E.R. Polysaccharide synergism-more questions than answers?. In: Harding S.E., Hill S.E., and Mitchell J.R. (Eds). Biopolymer Mixtures (1995), Nottingham University Press, Nottingham, UK 247-288
24. Nitta Y., Kim B.S., Nishinari K., Shirakawa M., Yamatoya K., Oomoto T., and Asai I. Synergistic gel formation of xyloglucan/gellan mixtures as studied by rheology, DSC, and circular dichroism. Biomacromolecules 4 (2003) 1654-1660
25. Ruel-Gariépy F., and Leroux J.-C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58 (2004) 409-426
26. Shirakawa M., Yamatoya K., and Nishinari K. Tailoring of xyloglucan properties using an enzyme. Food Hydrocoll. 12 (1998) 25-28
27. Suisha F., Kawasaki N., Miyazaki S., Shirakawa M., Yamatoya K., Sasaki M., and Attwood D. Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C. Int. J. Pharm. 172 (1998) 27-32
28. Takahashi A., Suzuki S., Kawasaki N., Kubo W., Miyazaki S., Loebenberg R., Bachynsky J., and Attwood D. Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats. Int. J. Pharm. 246 (2002) 179-186
29. Thakur B.R., Singh R.K., and Handa A.K. Chemistry and uses of pectin-a review. Crit. Rev. Food Sci. Nutr. 37 (1997) 47-73
30. Watanabe A., Hanawa R., and Sugihara M. Application of glycerogelatin as oral dosage form for the elderly. Yakuzaigaku 54 (1994) 77-87
31. Yamaoka K., Tanigawara Y., Nakagawa T., and Uno T. Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4 (1981) 879-885
32. 1H-n.m.r. spectroscopy and fast-atom-bombardment mass spectrometry. Carbohydr. Res. 200 (1990) 9-31